Registry of Lobbyists
| Corporation: | GlaxoSmithKline |
| Associated registration: | 953603-5088-55 |
| Communication date: | 2023-06-06 |
| Posted date: | 2023-07-15 |
| Designated Public Office Holders who participated in the communication: |
Andy Fillmore,
Member of Parliament
House of Commons Rodrigo Arancibia, Director Life Science Industries Directorate, Innovation, Science and Economic Development Canada (ISED) Darryl Patterson, Director General Biomanufacturing Strategy Implementation Team, Innovation, Science and Economic Development Canada (ISED) Ritu Banerjee, Assistant Deputy Minister Office of Life Sciences and Biomanufacturing Readiness , Innovation, Science and Economic Development Canada (ISED) |
| Subject Matter of the communication: | Economic Development, Health |
| Responsible Officer who filed this communication report: | Sridhar Venkatesh |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |